You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 21, 2024

Litigation Details for Biogen Inc. v. Zydus Worldwide DMCC (D. Del. 2023)

✉ Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Biogen Inc. v. Zydus Worldwide DMCC
The small molecule drug covered by the patents cited in this case is ⤷  Sign Up .

Details for Biogen Inc. v. Zydus Worldwide DMCC (D. Del. 2023)

Date Filed Document No. Description Snippet Link To Document
2023-07-06 1 Complaint U.S. Patent Nos. 8,669,281 (“the ’281 patent”); 9,090,558 (“the ’558 patent”); and 10,080,733 (“the … 1. This is an action for patent infringement under the patent laws of the United States, Title…the ’733 patent”) (collectively “the Asserted Patents”). Zydus notified Plaintiffs that it had submitted…Asserted Patents in the event that Zydus’s ANDA Product is approved before the Asserted Patents expire.…assignee of the ’281 patent. 26. BSM is the exclusive licensee of the ’281 patent. 27. External link to document
2023-07-06 4 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,669,281 B1; 9,090,558 B2; 10,080,733 B2. … 6 July 2023 1:23-cv-00732 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.